Last update 01 Nov 2024

CACNA1G-AS1 x BCMA x CD3

Basic Info

Related Targets
CACNA1G-AS1BCMACD3

Related

1
Drugs associated with CACNA1G-AS1 x BCMA x CD3
BCMA-CS1 HLE BiTE
Target
BCMA x CACNA1G-AS1 x CD3
Mechanism
BCMA inhibitors [+2]
Active Org.
Nanjing Anjin Pharmaceutical Co., Ltd.
Originator Org.
Nanjing Anjin Pharmaceutical Co., Ltd.
Active Indication
Multiple Myeloma
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with CACNA1G-AS1 x BCMA x CD3
Login to view more data
100 Translational Medicine associated with CACNA1G-AS1 x BCMA x CD3
Login to view more data
0 Patents (Medical) associated with CACNA1G-AS1 x BCMA x CD3
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free